Published in
Nature Research, Nature Medicine, 5(28), p. 1097-1097, 2022
DOI: 10.1038/s41591-022-01827-x
Links
Tools
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
Journal article published in 2022 by
Irene Ganan-Gomez 
,
Hui Yang,
Feiyang Ma ,
Guillermo Montalban-Bravo,
Natthakan Thongon,
Valentina Marchica,
Guillaume Richard-Carpentier,
Kelly Chien ,
Ganiraju Manyam ,
Feng Wang,
Ana Alfonso,
Shuaitong Chen,
Caleb Class ,
Rashmi Kanagal-Shamanna ,
Justin P. Ingram
and other authors.
,
Hui Yang,
Feiyang Ma ,
Guillermo Montalban-Bravo,
Natthakan Thongon,
Valentina Marchica,
Guillaume Richard-Carpentier,
Kelly Chien ,
Ganiraju Manyam ,
Feng Wang,
Ana Alfonso,
Shuaitong Chen,
Caleb Class ,
Rashmi Kanagal-Shamanna ,
Justin P. Ingram
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 